in the agreement. As of 31 March 2020, the establishment of this new company is still in progress, so the capital payment has not been done yet. Unit: Baht million 1Q20 1Q19 Change Hotel business 875
www.interpharma.co.th 6. Approve to present to the Shareholders' Meeting to consider and approve the issuance of debentures in the amount not exceeding 300 million Baht. The total debt burden of the Company at any one
the followings; • Net cash received from operating activities Baht 450 million consisting of cash inflow from sales and services, offsetting with cash outflow for expenses and income tax payment • Cash
of cash inflow from sales and services, offsetting with cash outflow for expenses and income tax payment • Cash inflow from financing activities Baht 1,820 million consisted of proceed of short-term
of cash inflow from sales and services, offsetting with cash outflow for expenses and income tax payment Cash inflow from financing activities Baht 1,820 million consisted of proceed of short-term
1,225,963 16.7 Impairment loss on loans and debt securities 763,224 2,313,121 (1,549,897) (67.0) Profit from operating before income tax expenses 6,956,258 6,490,011 466,247 7.2 Income tax expenses 1,190,205
7,352,410 1,225,963 16.7 Impairment loss on loans and debt securities 763,224 2,313,121 (1,549,897) (67.0) Profit from operating before income tax expenses 6,956,258 6,490,011 466,247 7.2 Income tax expenses
Placement) (Attachment 4)) (“Allocation of Convertible Debenture”) For the consideration of the acquisition and acceptance of the SUTGH’s entire business transfer instead of cash payment (Payment in Kind
omission of dividend payment for the year 2019. Opinion of the Board of Directors See as appropriate for the shareholders to approve the omission of dividend payment for the year 2019 due to accumulated loss
. Administrative expenses decreased by Baht 5.37 million due to: ➢ In 2017, The Company regained bad debt amounting to Baht 3.41 million. ➢ Front end fee for credit decreased by Baht 2. 55 million because Q1/2017